Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Jonckheere

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cells, Tissues, Organs|January 5, 2021
Epithelial-Mesenchymal Transition (EMT) as a Therapeutic TargetSven Jonckheere, Jamie Adams, Dominic De Groote, et al.
Molecular Cancer Research : MCR|June 24, 2022
Distinct Transcriptional Programs in Ascitic and Solid Cancer Cells Induce Different Responses to Chemotherapy in High-Grade Serous Ovarian CancerNele Loret, Niels Vandamme, Jordy De Coninck, et al.
Cell Death and Differentiation|May 9, 2025
Development and validation of a high-throughput screening pipeline of compound libraries to target EMTSven Jonckheere, Joachim Taminau, Jamie Adams, et al.
Nature Cancer|February 5, 2022
Zeb2 drives invasive and microbiota-dependent colon carcinomaKarolina Slowicka, Ioanna Petta, Gillian Blancke, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cells, Tissues, Organs|January 5, 2021
Epithelial-Mesenchymal Transition (EMT) as a Therapeutic TargetSven Jonckheere, Jamie Adams, Dominic De Groote, et al.
Molecular Cancer Research : MCR|June 24, 2022
Distinct Transcriptional Programs in Ascitic and Solid Cancer Cells Induce Different Responses to Chemotherapy in High-Grade Serous Ovarian CancerNele Loret, Niels Vandamme, Jordy De Coninck, et al.
Cell Death and Differentiation|May 9, 2025
Development and validation of a high-throughput screening pipeline of compound libraries to target EMTSven Jonckheere, Joachim Taminau, Jamie Adams, et al.
Nature Cancer|February 5, 2022
Zeb2 drives invasive and microbiota-dependent colon carcinomaKarolina Slowicka, Ioanna Petta, Gillian Blancke, et al.
Pageof 1